Novel scalable 3D cell based model for in vitro neurotoxicity testing: Combining human differentiated neurospheres with gene expression and functional endpoints.
暂无分享,去创建一个
Catarina Brito | Margarida Serra | Paula Marques Alves | Catarina Pinto | P. Alves | C. Brito | M. Serra | A. P. Terrasso | Ana Paula Terrasso | C. Pinto | Augusto Filipe | Susana Almeida | Ana Lúcia Ferreira | Pedro Pedroso | A. Filipe | S. Almeida | P. Pedroso | A. L. Ferreira
[1] M. Coleman,et al. Single-Cell ELISA and Flow Cytometry as Methods for Highlighting Potential Neuronal and Astrocytic Toxicant Specificity , 2011, Neurotoxicity Research.
[2] Hideki Mori,et al. Cultured stem cells as tools for toxicological assays. , 2013, Journal of bioscience and bioengineering.
[3] R. Swanson,et al. Astrocytes and Brain Injury , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[4] Sebastian Hoffmann,et al. Acute oral toxicity: variability, reliability, relevance and interspecies comparison of rodent LD50 data from literature surveyed for the ACuteTox project. , 2010, Regulatory toxicology and pharmacology : RTP.
[5] Fernando Quevedo Ricardi. Building a database , 2011 .
[6] P. Andrews,et al. Retinoic acid directs neuronal differentiation of human pluripotent stem cell lines in a non-cell-autonomous manner. , 2010, Differentiation; research in biological diversity.
[7] M. Dragunow,et al. Characterization of NTera2/D1 cells as a model system for the investigation of cannabinoid function in human neurons and astrocytes , 2011, Journal of neuroscience research.
[8] M. Stern,et al. Cellular phenotypes of human model neurons (NT2) after differentiation in aggregate culture , 2009, Cell and Tissue Research.
[9] L. O’Driscoll,et al. Three-dimensional cell culture: the missing link in drug discovery. , 2013, Drug discovery today.
[10] David H Rowitch,et al. Astrocytes and disease: a neurodevelopmental perspective. , 2012, Genes & development.
[11] J. Schwarz. Developmental perspectives on human midbrain-derived neural stem cells. , 2007, Parkinsonism & related disorders.
[12] P. Alves,et al. Integrating human stem cell expansion and neuronal differentiation in bioreactors , 2009, BMC biotechnology.
[13] Uwe Marx,et al. A multi-organ chip co-culture of neurospheres and liver equivalents for long-term substance testing. , 2015, Journal of biotechnology.
[14] E. Cattaneo,et al. Neural stem cell systems: physiological players or in vitro entities? , 2010, Nature Reviews Neuroscience.
[15] M. Stern,et al. Human Ntera2 cells as a predictive in vitro test system for developmental neurotoxicity , 2013, Archives of Toxicology.
[16] F. Brozzi,et al. S100B's double life: intracellular regulator and extracellular signal. , 2009, Biochimica et biophysica acta.
[17] Ana P. Teixeira,et al. A Comprehensive Metabolic Profile of Cultured Astrocytes Using Isotopic Transient Metabolic Flux Analysis and 13C-Labeled Glucose , 2011, Front. Neuroenerg..
[18] P. Alves,et al. Generation and genetic modification of 3D cultures of human dopaminergic neurons derived from neural progenitor cells , 2012 .
[19] G. Finocchiaro,et al. Immunotherapy against the radial glia marker GLAST effectively triggers specific antitumor effectors without autoimmunity , 2012, Oncoimmunology.
[20] J. DeFelipe,et al. Vesicular glutamate transporter 1 immunostaining in the normal and epileptic human cerebral cortex , 2005, Neuroscience.
[21] R. Pedersen,et al. Human embryonic stem cell derived astrocytes mediate non-cell-autonomous neuroprotection through endogenous and drug-induced mechanisms , 2011, Cell Death and Differentiation.
[22] S Coecke,et al. Evaluation of a proposed in vitro test strategy using neuronal and non-neuronal cell systems for detecting neurotoxicity. , 2006, Toxicology in vitro : an international journal published in association with BIBRA.
[23] P. Alves,et al. Novel culture strategy for human stem cell proliferation and neuronal differentiation , 2007, Journal of neuroscience research.
[24] Andreas Luch,et al. Drug-mediated toxicity: illuminating the 'bad' in the test tube by means of cellular assays? , 2012, Trends in pharmacological sciences.
[25] A. Bal-Price,et al. A human pluripotent carcinoma stem cell-based model for in vitro developmental neurotoxicity testing: Effects of methylmercury, lead and aluminum evaluated by gene expression studies , 2013, International Journal of Developmental Neuroscience.
[26] Nicola J. Allen,et al. Neuroscience: Glia — more than just brain glue , 2009, Nature.
[27] C. V. van Blitterswijk,et al. Spheroid culture as a tool for creating 3D complex tissues. , 2013, Trends in biotechnology.
[28] Thomas Dino Rockel,et al. Human Neurospheres as Three-Dimensional Cellular Systems for Developmental Neurotoxicity Testing , 2009, Environmental health perspectives.
[29] M. Coleman,et al. Differentiating human NT2/D1 neurospheres as a versatile in vitro 3D model system for developmental neurotoxicity testing. , 2008, Toxicology.
[30] W. Betz,et al. Imaging synaptic vesicle exocytosis and endocytosis with FM dyes , 2007, Nature Protocols.
[31] D. D. de Groot,et al. Neural progenitor cells as models for high-throughput screens of developmental neurotoxicity: state of the science. , 2010, Neurotoxicology and teratology.
[32] J. Clemente,et al. Improving expansion of pluripotent human embryonic stem cells in perfused bioreactors through oxygen control. , 2010, Journal of biotechnology.
[33] R. LoPachin,et al. Proteomic analysis of acrylamide-protein adduct formation in rat brain synaptosomes. , 2004, Toxicology and applied pharmacology.
[34] A. Hołownia,et al. Propofol protects rat astroglial cells against tert-butyl hydroperoxide-induced cytotoxicity; the effect on histone and cAMP-response-element-binding protein (CREB) signalling. , 2009, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.
[35] M. Ziman,et al. Nestin structure and predicted function in cellular cytoskeletal organisation. , 2005, Histology and histopathology.
[36] J. Exon. A Review of the Toxicology of Acrylamide , 2006, Journal of toxicology and environmental health. Part B, Critical reviews.
[37] P. Fisher,et al. Role of Excitatory Amino Acid Transporter‐2 (EAAT2) and glutamate in neurodegeneration: Opportunities for developing novel therapeutics , 2011, Journal of cellular physiology.
[38] R. Maganti,et al. Neurotoxic effects associated with antibiotic use: management considerations. , 2011, British journal of clinical pharmacology.
[39] Human NT2/D1 cells differentiate into functional astrocytes. , 1999, Neuroreport.
[40] M. Sofroniew,et al. Astrocytes: biology and pathology , 2009, Acta Neuropathologica.
[41] Robert H. Lee,et al. Three-dimensional neural constructs: a novel platform for neurophysiological investigation , 2008, Journal of neural engineering.
[42] M. O'hare,et al. Three-dimensional in vitro tissue culture models of breast cancer — a review , 2004, Breast Cancer Research and Treatment.
[43] Xiao-Ming Xu,et al. Glutamine synthetase down-regulation reduces astrocyte protection against glutamate excitotoxicity to neurons , 2010, Neurochemistry International.
[44] Thomas D. Schmittgen,et al. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.
[45] Elena Cattaneo,et al. Neural stem cell systems: physiological players or in vitro entities? , 2010, Nature Reviews Neuroscience.
[46] A. Federico,et al. Mitochondria, oxidative stress and neurodegeneration , 2012, Journal of the Neurological Sciences.
[47] James A Thomson,et al. Neural differentiation of human induced pluripotent stem cells follows developmental principles but with variable potency , 2010, Proceedings of the National Academy of Sciences.
[48] J. Trojanowski,et al. Increased levels of fucosyltransferase IX and carbohydrate Lewisx adhesion determinant in human NT2N neurons , 2007, Journal of neuroscience research.
[49] Austin G Smith,et al. Human Embryonic Stem Cells , 2005, Science.